严重感染和感染性休克早期集束化治疗临床分析  

Clinical Analysis of Early Cluster Therapy in Severe Infection and Septic Shock

作　　者：时玲燕[1] 

机构地区：[1]威海市立医院重症医学科,山东威海264200

出　　处：《中国继续医学教育》2017年第12期121-122,共2页China Continuing Medical Education

摘　　要：目的分析对严重感染和感染性休克进行早期集束化治疗的临床效果。方法选取在我院接受治疗的严重感染和感染性休克患者86例,随机分为常规治疗组和早期集束化治疗组,对比两组的临床治疗效果。结果早期集束化治疗组6 h和24 h治疗后的Scv O2、CVP、MAP指标明显优于常规治疗组相应指标,差异有统计学意义(P<0.05)。和常规治疗组相比,早期集束化治疗组的平均住院时间更短,死亡率更低,两组差异有统计学意义(P<0.05)。结论通过对严重感染和感染性休克患者进行早期集束化治疗,可以有效降低病死率,缓解患者多器官衰竭程度。Objective To analyze the clinical effect of early cluster therapy on severe infection and septic shock. Methods 86 cases of severe infection and septic shock treated in our hospital were randomly divided into routine treatment group and early cluster therapy group, and the clinical effects of the two groups were compared. Results The ScvO2, CVP and MAP indexes of the early cluster therapy group after 6 h and 24 h treatment were better than that of the conventional treatment group, the difference was statistically significant （P〈0.05）. Compared with the conventional treatment group, the average length of stay in the early cluster therapy group was shorter and the mortality rate was lower, the difference between the two groups was statistically significant （P〈0.05）. Conclusion Early cluster therapy in patients with severe infection and septic shock can effectively reduce the fatality rate and alleviate the degree of multiple organ failure in patients.

关 键 词：感染性休克 集束化治疗 感染 

分 类 号：R631.4[医药卫生—外科学]